Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing mefenamic acid and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mefenamic acid and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mefenamic acid- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mefenamic acid and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Mefenamic acid 10 mg/mL and paracetamol 25 mg/mL oral suspension |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Mefenamic acid 10 mg/mL and paracetamol 25 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cetirizine- and paracetamol- and phenylephrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Cetirizine and paracetamol and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing cetirizine and paracetamol and phenylephrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Cetirizine and paracetamol and phenylephrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely paracetamol 600 milligram/1 sachet powder for conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 600 milligram/1 sachet powder for conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 500 mg powder for oral solution sachet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 500 mg powder for oral solution sachet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 1 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely paracetamol 1 gram/1 sachet powder for conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only chlorzoxazone and diclofenac and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing chlorzoxazone and diclofenac and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing chlorzoxazone and diclofenac and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorzoxazone and diclofenac and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diclofenac and paracetamol and serrapeptase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing diclofenac and paracetamol and serrapeptase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing diclofenac and paracetamol and serrapeptase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Diclofenac and paracetamol and serrapeptase only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 10 mg/mL solution for infusion |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 10 mg/mL solution for infusion |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 10 mg/mL solution for infusion and/or injection |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 10 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine 32 mg and paracetamol 500 mg oral capsule |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine 32 mg and paracetamol 500 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine- and guaifenesin- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine and guaifenesin and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine 30 mg and codeine phosphate 8 mg and paracetamol 500 mg oral capsule |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Caffeine 30 mg and codeine phosphate 8 mg and paracetamol 500 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing guaifenesin and paracetamol and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin and paracetamol and phenylephrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin and paracetamol and phenylephrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Guaifenesin- and paracetamol- and phenylephrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only dextromethorphan and paracetamol and promethazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only dextromethorphan and paracetamol and promethazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing dextromethorphan and paracetamol and promethazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing dextromethorphan and paracetamol and promethazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Dextromethorphan hydrobromide 750 microgram/mL and paracetamol 50 mg/mL and promethazine hydrochloride 1 mg/mL oral solution |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Dextromethorphan hydrobromide 750 microgram/mL and paracetamol 50 mg/mL and promethazine hydrochloride 1 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Diphenhydramine hydrochloride 2.5 mg/mL and paracetamol 24 mg/mL oral solution |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Diphenhydramine hydrochloride 2.5 mg/mL and paracetamol 24 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Buclizine- and codeine- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only buclizine and codeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only buclizine and codeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing buclizine and codeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely ibuprofen 150 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely ibuprofen 150 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Brompheniramine- and caffeine- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only brompheniramine and caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely diphenhydramine hydrochloride 12.5 milligram and paracetamol 500 milligram and pseudoephedrine hydrochloride 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely diphenhydramine hydrochloride 12.5 milligram and paracetamol 500 milligram and pseudoephedrine hydrochloride 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing diphenhydramine and paracetamol and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Diphenhydramine and paracetamol and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only diphenhydramine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Diphenhydramine- and paracetamol- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Ibuprofen (as ibuprofen sodium) 3 mg/mL and paracetamol 10 mg/mL solution for infusion |
Has precise active ingredient |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ibuprofen (as ibuprofen sodium) 3 mg/mL and paracetamol 10 mg/mL solution for infusion |
Has basis of strength substance (attribute) |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ibuprofen and paracetamol only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ibuprofen- and paracetamol-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acetaminophen measurement, urine (procedure) |
Component |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acetaminophen blood measurement (procedure) |
Component |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum paracetamol measurement (procedure) |
Component |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Salicylate/paracetamol screening |
Component |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of acetaminophen in gastric fluid (procedure) |
Component |
True |
Paracetamol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |